Spinal and Bulbar Muscular Atrophy Clinical Trial
Official title:
A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, First-In-Patient Study Of AJ201 To Evaluate Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics In Adults With Spinal And Bulbar Muscular Atrophy (SBMA)
This is a phase 1/2a randomized, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of study drug AJ201 in subjects with Spinal and Bulbar Muscular Atrophy (SBMA).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04944940 -
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
|
||
Recruiting |
NCT03555578 -
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
|
||
Completed |
NCT00303446 -
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
|
Phase 2 | |
Recruiting |
NCT06411912 -
A Study of NIDO-361 in Patients With SBMA
|
Phase 2 | |
Completed |
NCT02156141 -
High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
|
N/A | |
Completed |
NCT02024932 -
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
|
Phase 2 | |
Recruiting |
NCT06169046 -
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
|
Phase 2 |